Cardiology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Looking for a medical communications company? MedWrite International specializes in delivering global strategic medical marketing communications. Visit MedWrite's site to learn more.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 4.
FAIR-HF: Intravenous iron improves chronic heart failure outcomes
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Intravenous iron treatment improves multiple clinical outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction, regardless of whether or not they also have anemia, according to data from the FAIR-HF study.
Source: MedWire News - Cardiology - November 18, 2009 Category: Cardiology Source Type: news
HeartMate II: Continuous-flow left ventricular assist device outperforms pulsatile-flow device in advanced heart failureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A continuous-flow left ventricular assist device achieved superior outcomes to a pulsatile-flow LVAD in patients with advanced heart failure. In the HeartMate II Destination Therapy clinical trial, 2-year survival for patients implanted with the continuous-flow device was more than double that of patients implanted with the pulsatile-flow device.
Source: MedWire News - Cardiology - November 18, 2009 Category: Cardiology Source Type: news
Is Surface ECG a Useful Surrogate for Subcutaneous ECG?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion: Surface ECGs are adequate surrogates for subcutaneous ECGs in situations free from motion artifacts but not in situations involving movement of the device, surface electrodes, or recording equipment. During artifact-inducing maneuvers, subcutaneous ECGs are of higher quality and less susceptible to artifacts than surface ECGs. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: CARISSA L. BELLARDINE BLACK, KURT STROMBERG, GEORGETTE PLEMPER VAN BALEN, RAJA N. GHANEM, ROBERT W. BREEDVELD, ROBERT G. TIELEMAN Source Type: journals
Psychopathology in Patients with ICDs over Time: Results of a Prospective StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:Patients receiving ICDs have significant rates of baseline psychopathology after implantation. However, psychological assessment scores tend to improve with time. ICD shocks do not appear to significantly impact psychological state. These results suggest the importance of close screening and referral for possible psychopathology in patients receiving ICDs, especially in the peri-implant period. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: SURAJ KAPA, DEBRA ROTONDI-TREVISAN, ZANA MARIANO, THERESA AVES, JANE IRVINE, PAUL DORIAN, DAVID L. HAYES Source Type: journals
The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia PacingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion:ATP delivered from a LCV lead offers no efficacy advantage over pacing from the RVA. (PACE 2009; 1[ndash]6)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: RAYMOND YEE, ULRIKA BIRGERSDOTTER-GREEN, PAUL BELK, TROY JACKSON, JILL CHRISTENSEN, MARK S. WATHEN Source Type: journals
Determining Arrhythmia Mechanism: Still Critical or Now Obsolete?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: FRANK C. CHEN, SAMUEL J. ASIRVATHAM Source Type: journals
Mapping and Isolation of the Pulmonary Veins Using the PVAC CatheterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:(1) PVAC-guided ablation (i.e., mapping and ablation with a single catheter) results in isolation of all PVs in 73% of the patients. (2) An additional circular mapping catheter is required to increase complete isolation rate to 93% of the patients. (3) Given the esophageal T° rise in almost 50% of patients, safety precautions are needed. (PACE 2009; 1[ndash]11)
Source: Pacing and Clinical Electrophysiology : PACE - November 18, 2009 Category: Cardiology Authors: MATTIAS DUYTSCHAEVER, WIM ANNE, GIORGI PAPIASHVILI, YVES VANDEKERCKHOVE, RENE TAVERNIER Source Type: journals
Journal Scan: Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness (N Engl J Med 2009;Nov 15:[Epub ahead of print].)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In the ARBITER 6-HALTS trial, patients with coronary heart disease or a coronary heart disease risk equivalent, who were receiving long-term statin therapy, with a low-density lipoprotein (LDL) cholesterol under 100 mg/dl and a high-density lipoprotein (HDL) cholesterol under 50 mg/dl for men or 55 . . .
Source: Cardiosource - November 18, 2009 Category: Cardiology Source Type: organizations
Expert Opinion: CCA Focus: Palliative Care in Congestive Heart FailureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Cardiosource - November 18, 2009 Category: Cardiology Source Type: organizations
Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries. Patients in this first phase of the ABSORB trial experienced no stent thrombosis (blood clots) out to three years and no new major adverse cardiac events (MACE1) between six months and three years (3.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
CDC data show LDL screening rate remains stagnant; many who could benefit go without lipid-lowering drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Editorialists discuss simplifying LD-management guidelines in light of a CDC study in which two-thirds of subjects who are at high risk for developing coronary disease within 10 years and eligible for lipid-lowering drugs were not on the medication.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
JACC: For mitral regurgitation, 3D echo passes the litmus testEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In a head-to-head comparison with velocity-encoded cardiac MR to measure mitral regurgitation, real-time 3D echocardiography proved feasible and accurate. In addition, researchers found that the currently recommended 2D echo approach significantly underestimated both the effective regurgitant orifice area and the regurgitant volume.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
RE-LY: Post hoc analysis confirms benefit of dabigatran relative to warfarin at all INR levelsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new analysis confirms that regardless of INR control achieved across participating centers, dabigatran remained noninferior at the lower dose and superior at the higher dose to warfarin for prevention of stroke and systemic embolism.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Cardiologists shocked by new FDA alert on clopidogrel-PPI interactionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA has issued a new warning on an interaction between clopidogrel and the PPI omeprazole and other drugs that inhibit the CYP2C19 enzyme, just weeks after the only randomized trial on this issue reported no such interaction.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
AHA: Mummies Show Evidence of Vascular Disease (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Clogged arteries were around long before fast food restaurants dotted the world map and obesity became epidemic, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Abbott gains access to BG Medicine biomarkerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott and BG Medicine will partner to develop galectin-3, a protein that advances cardiac fibrosis, to better understand the evolution of heart failure.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
Merck to strengthen work for cardio healthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Subsequent to the completed $41 billion merger with Schering-Plough, Merck said today that it will continue its research to expand and market treatments for cardiovascular disorders.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
Statins do not eliminate risk of low HDL-cholesterol levelsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers say a new study shows that statins don't alter the risks associated with low HDL-cholesterol levels and that raising HDL cholesterol 10 mg/dL could prevent an additional eight MIs per 1000 patient-years.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
'Bad' Cholesterol Rates Plummet (CME/CE, with video)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The percentage of Americans with high levels of low-density lipoprotein (LDL) cholesterol dropped by one-third between 2000 and 2006, but screening rates remained suboptimal, researchers said.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Women Suffering Sudden Cardiac Arrest Have Lower Prevalence Of Structural Heart Disease Compared To MenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart's pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology. The lack of left ventricular dysfunction could mean that fewer women meet current medical guidelines for implantable cardiac defibrillators that can prevent sudden cardiac arrest, says the study's lead researcher.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
AHA: Accident Kills Noted CardiologistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- A Harvard cardiologist was killed here Monday when he was hit by a car while jogging. Kenneth Baughman, MD, 63, director of the advanced heart disease program at Brigham and Women's Hospital, was attending the American Heart Association meeting.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Kenneth Baughman killed while jogging at AHAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Kenneth Baughman, a cardiologist at Brigham and Women's Hospital, died Monday morning in Orlando, FL, when he was struck by a car while out for a morning run.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
AHA: FDA Drops Clopidogrel Bomb at AHAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, thus increasing the risk of myocardial infarction and stroke.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
AHA: Active Video Games Can Break a Sweat (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Active video games such as Wii Sports or Wii Fit may provide the equivalent of a moderate intensity workout, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
AHA: New Trumps Old in Comparison of Heart Pumps (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- A newer-generation left ventricular assist device, HeartMate II, improved outcomes more as destination therapy for advanced heart failure than an older device, HeartMate XVE, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Anthracycline cardiotoxicity appears limited in breast cancer in the short termEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No significant incidence of short-term cardiac toxicity was observed in breast-cancer patients on dose-dense anthracycline regimens, but longer-term follow-up is needed.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Telephone-Delivered Care For Treating Depression After CABG Surgery Appears To Improve OutcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
AHA: Correcting Iron Helps in CHF, Anemia or Not (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Treating iron deficiency in heart failure patients makes patients feel better even in the absence of anemia, according to a randomized trial.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
AHA: Aspirin alone good enough to prevent vein graft diseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—The addition of clopidogrel to aspirin did not lead to a significant reduction in vein graft intimal hyperplasia during the first year after CABG, according to the CASCADE trial presented Monday during the late-breaking clinical trials session at the 2009 American Heart Association conference.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
POPE: No benefit of diclofenac on pericardial effusionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Mean pericardial effusion grade postcardiac surgery was not reduced with 14 days of treatment with the NSAID.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
CASCADE: No significant benefit of clopidogrel in reducing graft disease after CABGEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dual antiplatelet therapy did not significantly reduce vein graft intimal hyperplasia compared with aspirin alone over 12 months.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Healthy Older Adults Not At Risk From Exercise-Linked Ventricular TachycardiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Healthy, older adults free of heart disease need not fear that bouts of rapid, irregular heartbeats brought on by vigorous exercise might increase short- or long-term risk of dying or having a heart attack, according to a report by heart experts at Johns Hopkins and the U.S. National Institute on Aging (NIA).
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Patients At UCSD Hospital Three Times More Likely To Survive Cardiac Arrest With New Advanced Resuscitation Training ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZOLL Medical Corporation (NasdaqGS: ZOLL) announced that in a "Best of the Best" presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest. Dr.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
AHA: Doctor-Patient Efforts to Lower BP Fizzle Long Term (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Training physicians on evidence-based treatment and how to tackle lifestyle issues with their hypertensive patients drops blood pressure if patients get regular counseling as well, but both flop long term for a population already at target.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Trans-catheter aortic valve implantation comes of ageEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Trans-catheter aortic valve implantation, using either of two commercially available bioprosthetic valves, has almost 100% success in the hands of interventionists trained in this technique, according to results of the first prospective registry to follow high-risk patients undergoing the procedure.
Source: MedWire News - Heart Failure - November 17, 2009 Category: Cardiology Source Type: news
Prehypertension increases risk for atherosclerosis in Type 2 diabeticsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Prehypertension increases the risk for atherosclerosis in patients with Type 2 diabetes independently of other factors, show study results.
Source: MedWire News - Hypertension - November 17, 2009 Category: Cardiology Source Type: news
Primary PCI safe to perform with no on-site cardiac surgery supportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
There is no difference in mortality among patients with ST-elevation myocardial infarction who undergo primary angioplasty at hospitals where there is and where there is not cardiac surgery on-site (SOS), data from a registry-based study suggest.
Source: MedWire News - Cardiology - November 17, 2009 Category: Cardiology Source Type: news
AHA: Acute heart attack patients’ radiation dose of concernEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Acute heart attack patients admitted to academic hospitals average a cumulative effective radiation dose of 14.52 mSv from imaging and other procedures. Researchers cautioned physicians to be aware of the cumulative effect of all ionizing radiation tests, rather than just focusing on the dose of each exam. The study was presented at the 2009 American Heart Association (AHA) meeting in Orlando, Fla., on Monday.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
AHA: Pre-hospital trans-nasal cooling improves cardiac arrest outcomesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—European researchers found that a trans-nasal cooling approach that lowers body temperature while cardiopulmonary resuscitation (CPR) is performed can be used effectively in the pre-hospital setting and appears to improve outcomes, based on the PRINCE study presented at the 2009 American Heart Association conference.
Source: Cardiovascular Business News - November 17, 2009 Category: Cardiology Tags: Latest News Source Type: news
HEAAL: High-dose trumps low-dose ARB for heart failure in the ACE-inhibitor intolerantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The randomized trial, which compared losartan dosages of 150 mg/day and 50 mg/day, "makes a strong case for the value of incremental inhibition of the renin-angiotensin system," its authors say.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
FAIR-HF: Symptom improvement, functional gains follow correction of iron deficiency in heart failureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The randomized, placebo-controlled study's intriguing wrinkle: the benefits after 24 weeks of treatment with an injectable form of iron were independent of whether the patients were anemic.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
HeartMate II continuous-flow VAD sets new benchmark in destination-therapy trialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Thoratec's HeartMate II continuous-flow VAD keeps about half of patients alive and stroke- or reintervention-free after two years in pivotal destination therapy trial.
Source: theHeart.org - November 17, 2009 Category: Cardiology Source Type: info
Aterovax's SPLA2 Activity Test Significantly Improves Prediction Of Cardiovascular Events In Large Prospective StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease (CAD) over a 5 year period, independent of established risk markers, including C-reactive protein.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
AHA: Tripling ARB Dose Improves HF Outcomes (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- High doses of the angiotensin receptor blocker (ARB) losartan (Cozaar) for heart failure patients who cannot tolerate an ACE inhibitor may reduce mortality and heart failure hospitalization, researchers found.
Source: MedPage Today Cardiovascular - November 17, 2009 Category: Cardiology Source Type: news
Key Omega-3 Fatty Acid Increased By Oil From Biotech SoybeansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Oil from soybeans modified through biotechnology increased levels of omega-3 eicosapentaenoic acid (EPA) in red blood cells according to research presented at the American Heart Association's Scientific Sessions 2009. "This soybean oil could be an effective alternative to fish oil as a source of heart-healthy omega-3 fatty acids," said William Harris, Ph.D.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Scientific Meeting On Latest Breakthroughs And Techniques For Improving Success Rate Of Chronic Total OcclusionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHAT: The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Post-Discharge, Elevated Biomarkers Lead To Diminished Quality Of Life In Heart Attack PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. The study examined a subset of patients in a 4,500-patient heart attack registry from 24 24 U.S. hospitals and found: 9 percent had elevated levels of the biomarker troponin (TnT) after six months.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Analysis Shows Bystanders Can Save More Lives When Doing Chest Compressions Only Instead Of Mouth-To-mouth CPREmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The chance of surviving a cardiac arrest outside a hospital was found to be twice as high when bystanders performed continuous chest compressions without mouth-to-mouth breathing than when bystanders performed standard CPR. These are the latest findings reported by the Resuscitation Research Group at the University of Arizona Sarver Heart Center and the SHARE Program (Save Hearts in Arizona Research and Education) at the Arizona Department of Health Services.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Comparing Two Surgical Strategies For Infant Heart DefectEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Infants born with a severely underdeveloped heart are more likely to survive to their first birthday when treated with a new shunt procedure - yet it may not be the safest surgery long term, according to research presented at the American Heart Association's Scientific Sessions 2009. Babies born with a critically underdeveloped left side of their hearts require three surgeries to correct the problem.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Early Cooling In Cardiac Arrest May Improve SurvivalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association's Scientific Sessions 2009. "We now have a method that is safe and can be started within minutes of cardiac arrest to minimize damage during this very critical period," said Maaret Castrén, M.D., lead author of the study and professor of emergency medicine at the Karolinska Institute in Stockholm.
Source: Cardiovascular / Cardiology News From Medical News Today - November 17, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
